Noah Clauser - 01 Mar 2022 Form 4 Insider Report for Astria Therapeutics, Inc. (ATXS)

Role
Chief Financial Officer
Signature
/s/ Noah Clauser
Issuer symbol
ATXS
Transactions as of
01 Mar 2022
Net transactions value
$0
Form type
4
Filing time
03 Mar 2022, 18:20:59 UTC
Previous filing
02 Jun 2021
Next filing
06 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATXS Stock Option (right to buy) Award $0 +55,000 $0.000000 55,000 01 Mar 2022 Common Stock 55,000 $6.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on March 1, 2022, and is subject to vesting over a four year period, with 25% of the shares vesting on the first anniversary of February 17, 2022 and the remainder vesting over the ensuing three years at a rate of 2.0833% per month.